- Charles Wiener, Anthony S. Fauci, Eugene Braunwald, Dennis L. Kasper, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo,
Harrison's Principles of Internal Medicine 16th
Edition, March 6, 2008
- Rich KT, Safranek S. PPIN's clinical inquiries. Medical treatment
of benign prostatic hyperplasia. Am Fam Physician .
2008;77:665-666.
- Alfred F Tallia, Dennis A. Cardone, David F. Howarth, Kenneth H Ibsen, Swanson's Family Medicine Review,
Fourth Edition, 2001; 503-505
- Traves D Crabtree, Eugen Foley, Robert Sawyer:
Surgical Specialties - Board Review Series
-
Chuang AY, Demarzo AM, Veltri RW, Sharma RB, Bieberich
CJ, Epstein JI (2007). "Immunohistochemical Differentiation
of High-grade Prostate Carcinoma From Urothelial Carcinoma".
The American Journal of Surgical Pathology 31 (8):
1246–1255.
- Andriole, GL; Roehrborn C, Schulman C, Slawin KM,
Somerville M, Rittmaster RS (September 2004). "Effect of
dutasteride on the detection of prostate cancer in men with
benign prostatic hyperplasia". Urology 64 (3): 537–41;
discussion 542–3.
- Bent S, Kane C, Shinohara K, et. al. Saw palmetto for benign prostatic hyperplasia. NEJM . 2006; 354:557-566.
*The
information provided on this site is for informational and
educational purposes only and is not intended as a substitute for professional medical advice, treatment or diagnosis.
The website is not intended to provide medical advice, and does not provide medical advice.
Consult a licensed Medical practitioner for further clarification. In medical emergencies, please call 911 for urgent attention.
Do not copy-duplicate any material on this site.
|
